08Jun
FDA Signals a Deliberative Approach to Cannabis at Public Hearing
While it was ostensibly convened to gather scientific input from stakeholders on how to appropriately regulate cannabis-infused products, the Food and Drug Administration (FDA) also used the May 31, 2019 public hearing as a platform to issue a call...
By:
Wilson Sonsini Goodrich & Rosati
Related
On June 18, 2019, Governor Ned Lamont signed into law Connecticut’s new sexual harassment preventio...
Read More >
World Law Group member firms recently collaborated on a Global Venture Capital Guide that covers mor...
Read More >
The UK Competition and Markets Authority ("CMA") recently issued its Annual Plan for 2020/2021, whic...
Read More >
WASHINGTON -- The U.S. Equal Employment Opportunity Commission (EEOC) today announced the newest edi...
Read More >
While the number of confirmed Coronavirus or COVID-19 (“Coronavirus”) cases keeps rising worldwide...
Read More >
CBInsights recently hosted a webcast, The State of Healthcare Q2 2020. Capital raising by companies ...
Read More >